Automated news aggregation. Headlines and summaries are gathered from public feeds; see our editorial standards for sourcing, corrections, and AI-assist disclosure.
Related coverage: UMMC gets $2.6M grant for prostate cancer research WJTV
This story was aggregated from WJTV. Headlines, summaries, and links are gathered automatically from public RSS feeds for your convenience.
Read the full story →Related coverage: Seattle Children’s gets $700k in grants for pediatric cancer research kiro7.com
kiro7.com · 3 hours ago
Related coverage: New drug to treat one of the deadliest cancers is 'the real deal,' oncologist says ksl.com Acquired resistance to the RAS(ON) multi-selective inhibitor daraxonrasib guides rational combination therapy strategies in pancreatic cancer Nature Pancreatic Cancer Specialists Getting a Jump on Daraxonrasib Medscape Patients in Illinois starting to receive experimental pancreatic cancer drug: ‘Game changer’ Chicago Tribune Stanford expands access to revolutionary pancreatic cancer drug Stanford Medicine
ksl.com · 3 hours ago
Related coverage: MU School of Medicine receives $1 million cancer research grant Columbia Missourian
Columbia Missourian · 5 hours ago
Related coverage: FDA Does Not Approve 177Lu-Edotreotide for GEP-NETs Targeted Oncology
Targeted Oncology · 5 hours ago